期刊文献+

河北省农村菌痢患者疾病经济负担及其影响因素研究 被引量:13

Study on Economic Burden of Shigellosis Patients and the Related Factors in Countryside of Hebei Province
下载PDF
导出
摘要 目的通过测算河北省正定县菌痢患者的直接医疗费用、直接非医疗费用和间接费用来评价河北省农村菌痢患者一次患病经济负担,探讨影响菌痢疾病经济负担的因素。方法菌痢患者的直接经济负担通过问卷调查获得,间接经济负担采用人力资本法估算,运用多元线性回归模型分析疾病经济负担的影响因素。结果307例菌痢患者的人均直接医疗费用为19.6元,人均间接经济负担为21.3元(按收入)或65.9元(按GDP)。多因素分析结果显示,年龄、病程和给药方式是影响菌痢病人疾病经济负担的主要因素。结论河北省农村地区居民大部分菌痢患者的病情较轻,其直接经济负担和间接经济负担并不重;但少数病情较重或病程迁延的患者医疗费用较高,因此仍需加强对该地区菌痢的防治工作。 OBJECTIVE to study the economic burden of shigellosis patients and the related factor in countryside of Hebei province. METHOD Questionnaire and human capital method were used in calculation of economic burden of disease and the multi linear regression model was explored to analyze the factors. RESULT Direct economic burden of each person was 19.6 RMB, the indirect economic burden was 21.3 RMB (Income) or 65.9 RMB (GDP). Age, the course of shigellosis and the treatment were main factors which influenced economic burden of shigellosis. CONCLUSION The economic burden of most shigellosis patients with milder shigellosis in countryside of Hebei province was not very high. However, the expenditure of some patients was in excess of what the patient could afford because shigellosis was deteriorated or the course prolnged. It was still necessary to strengthen the prevention and control of shigellosis.
出处 《中国初级卫生保健》 2007年第3期9-12,共4页 Chinese Primary Health Care
基金 国际疫苗研究所DOMI项目资助(S-SE-4)。
关键词 细菌性痢疾 直接经济负担 间接经济负担 人力资本法 shigellosis, direct economic burden, indirect economic burden, human capital method
  • 引文网络
  • 相关文献

参考文献4

二级参考文献29

  • 1楚金贵,贾国民,孙贺,杨成荣,杨志纲,刘岩,王欣.河北省传染病漏报调查综合分析[J].疾病监测,1996,11(6):218-220. 被引量:4
  • 2Sekhar C. Some Aspects of Drug Use in Ethiopia. Tropical Doctor. 1981(11): 116-124.
  • 3Calva J , Bojalil R. Antibiotic Use in a Periurban Community inMexico: A Household and Drug Store Survey. Social Science and Medicine. 1996, 42(8) : 1121-1129.
  • 4Classen D C. Adverse Drug Events in Hopitalized Patients: Excess Length of Stay, Extra Cost and Attfibutalbe Mortality. JAMA. 1997(227): 301-307.
  • 5Bates D W. The Cost of Adverse Drug Events in Hospitalized Patients. JAMA. 1997(227): 307-318.
  • 6Mark Fok , Angela Lo. Quantifying the Impact of Prescription-related Problems on Pharmacy Workload. Canj Hosp Pharm. 2002(55): 313-322.
  • 7王欣 刘岩.河北省2000年法定传染病漏报调查[J].河北预防医学杂志,2002,8:4-7.
  • 8Clemens J,Kofloff KL,Kay B.Generic protocol to estimate the burden of Shigella diJatrimea and dysenteric mortality; WHO/V&B/99.26[R].Geneva:WHO,1999.
  • 9Kotloff KL,Winickoff JP,Ivanoff B,et al.Global burden of Shigelta infections:implications for vaccine development and implementation of control strategies[J].Bull World Health Organ,1999,77:651 -666.
  • 10张成勤 朱寿水 阿不来提 等.新疆库尔勒农村腹泻病流行病学调查[J].中华流行病学杂志,1992,13(8):46-50.

共引文献44

同被引文献112

引证文献13

二级引证文献99

;
使用帮助 返回顶部